Sage Therapeutics (SAGE) Competitors

Sage Therapeutics (NASDAQ:SAGE) and Disc Medicine (NASDAQ:IRON) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.

Is SAGE or IRON more profitable?

Disc Medicine has a net margin of 0.00% compared to Sage Therapeutics' net margin of -971.50%. Disc Medicine's return on equity of -25.24% beat Sage Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sage Therapeutics	-971.50%	-68.18%	-60.84%
Disc Medicine	N/A	-25.24%	-23.96%

Do institutionals & insiders have more ownership in SAGE or IRON?

99.2% of Sage Therapeutics shares are owned by institutional investors. Comparatively, 83.7% of Disc Medicine shares are owned by institutional investors. 5.5% of Sage Therapeutics shares are owned by company insiders. Comparatively, 4.2% of Disc Medicine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Which has higher valuation & earnings, SAGE or IRON?

Disc Medicine has lower revenue, but higher earnings than Sage Therapeutics. Disc Medicine is trading at a lower price-to-earnings ratio than Sage Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sage Therapeutics	$47.40M	8.94	-$400.67M	-$5.80	-1.17
Disc Medicine	N/A	N/A	-$76.43M	-$3.92	-12.97

Does the media favor SAGE or IRON?

In the previous week, Disc Medicine had 9 more articles in the media than Sage Therapeutics. MarketBeat recorded 14 mentions for Disc Medicine and 5 mentions for Sage Therapeutics. Disc Medicine's average media sentiment score of 1.07 beat Sage Therapeutics' score of 0.41 indicating that Disc Medicine is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sage Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Disc Medicine	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer SAGE or IRON?

Sage Therapeutics received 573 more outperform votes than Disc Medicine when rated by MarketBeat users. However, 85.71% of users gave Disc Medicine an outperform vote while only 64.79% of users gave Sage Therapeutics an outperform vote.

Company	Underperform	Outperform
Sage Therapeutics	Outperform Votes 633 64.79%	Underperform Votes 344 35.21%
Disc Medicine	Outperform Votes 60 85.71%	Underperform Votes 10 14.29%

Do analysts rate SAGE or IRON?

Sage Therapeutics presently has a consensus target price of $8.87, indicating a potential upside of 30.97%. Disc Medicine has a consensus target price of $96.70, indicating a potential upside of 90.13%. Given Disc Medicine's stronger consensus rating and higher probable upside, analysts clearly believe Disc Medicine is more favorable than Sage Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sage Therapeutics	1 Sell rating(s)	14 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.06
Disc Medicine	0 Sell rating(s)	0 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	3.09

Which has more volatility and risk, SAGE or IRON?

Sage Therapeutics has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Comparatively, Disc Medicine has a beta of 0.73, meaning that its share price is 27% less volatile than the S&P 500.

Summary

Disc Medicine beats Sage Therapeutics on 13 of the 18 factors compared between the two stocks.